Abiopharma

New Form SCHEDULE 13D/A - SHARING SERVICES GLOBAL Corp Filed: 2026-01-20 AccNo: 0001493152-26-002917 Size: 43 KB

New Form PRE 14A - HARVARD BIOSCIENCE INC Filed: 2026-01-20 AccNo: 0001171843-26-000345 Size: 1 MB

New Form SCHEDULE 13G - Forte Biosciences, Inc. Filed: 2026-01-20 AccNo: 0000902664-26-000316 Size: 17 KB

New Form SCHEDULE 13G/A - ENANTA PHARMACEUTICALS INC Filed: 2026-01-20 AccNo: 0001104659-26-005096 Size: 18 KB

New Form S-3 - LeonaBio, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-016699 Size: 1 MB

IQVIA - IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026

UTHR: Notification

New Form 4/A - ENSIGN GROUP, INC Filed: 2026-01-20 AccNo: 0001470396-26-000002 Size: 6 KB

Alcon - Alcon Completes $750 Million Share Repurchase Program

METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026

DuPont Announces Appointment of D.G. Macpherson to Board of Directors

UTHR: Notification

Halozyme - Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update

Aytu BioPharma Recaps Investor Day Held on January 20, 2026